Thrombocytopenia - PowerPoint PPT Presentation

About This Presentation
Title:

Thrombocytopenia

Description:

Thrombocytopenia Rahul Gladwin, MS3 University of Health Sciences-Antigua School of Medicine Thrombocytopenia Causes of Thrombocytopenia TTP/ITP Drug-induced ... – PowerPoint PPT presentation

Number of Views:786
Avg rating:3.0/5.0
Slides: 50
Provided by: rahulglad
Category:

less

Transcript and Presenter's Notes

Title: Thrombocytopenia


1
Thrombocytopenia
  • Rahul Gladwin, MS3
  • University of Health Sciences-Antigua
  • School of Medicine

2
Thrombocytopenia
  • Causes of Thrombocytopenia
  • TTP/ITP
  • Drug-induced Thrombocytopenia
  • HIV-associated Thrombocytopenia
  • Disseminated intravascular coagulation
  • Pancytopenia
  • Complications
  • Management
  • Case study

3
Definition
  • Thrombocytopenia is defined as a decrease in the
    number of platelets.
  • Normal platelet counts range from
    150,000-300,000/µL.
  • Anything below 100,000/µL constitutes
    thrombocytopenia.

4
Why does platelet count matter?
  • Platelets help form blood clots.
  • Unexplained epistaxis, petechiae, gingivorrhagia,
    and vaginal bleeding imply decreased platelet
    counts.
  • Platelet count below 20,000/µL causes spontaneous
    internal bleeding.
  • Platelet count between 20,000-50,000/µL
    aggravates post-traumatic bleeding.

5
Causes of thrombocytopenia
  • Causes of thrombocytopenia can be divided into
    four main classes
  • 1. Decreased production of platelets
  • 2. Decreased platelet survival
  • 3. Sequestration
  • 4. Dilutional

6
Decreased production of platelets
  • Bone marrow diseases e.g., aplastic anemia,
    Fanconis anemia, leukemia, disseminated cancer.
  • Medications alkylating agents, benzene,
    chloramphenicol, streptomycin, chlorpromazine,
    antimetabolites.
  • Insectides DDT, parathion
  • Viruses hepatitis, EBV virus, CMV.

7
Decreased production of platelets
  • Alcohol, thiazides, cytotoxic drugs, measles,
    HIV.
  • Vitamin B12 and folic acid deficiency.
  • Megaloblastic anemia, myelodysplastic syndromes.

8
Decreased platelet survival
  • Autoimmune idiopathic thrombocytopenic purpura,
    systemic lupus erythematosus, hemolytic-uremic
    syndrome, anti-platelet antibodies.
  • Isoimmune post-transfusion and neonatal.
  • Drug-associated quinidine, heparin, sulfa-drugs.
  • Infections infectious mononucleosis, HIV, CMV.

9
Sequestration
  • The spleen sequesters 30-40 of the bodys total
    platelets.
  • Splenomegaly secondary to hypersplenism.
  • Treatment is splenectomy.
  • Bone marrow biopsy shows increased megakaryocytes.

10
Question
  • What test do you order in order to differentiate
    between thrombocytopenia caused by decreased
    platelet production (ie., by cancer, drugs,
    autoimmune, chemotherapy, etc.) vs
    thrombocytopenia caused by increased
    sequestration?

11
Answer
  • Bone marrow biopsy shows increased megakaryocytes
    in thrombocytopenia caused by increased
    sequestration.
  • Presence of megakaryocytes implies that the
    bone-marrow is working over time in order to
    compensate for increased platelet loss.

12
Dilutional
  • Massive transfusions can produce thrombocytopenia
    because stored blood contains very little
    platelets.
  • Packed blood doesnt contain many thrombocytes.

13
Immune Thrombocytopenic Purpura
  • Causes autoimmune destruction of platelets
    secondary to HIV, SLE, viruses, and drugs.
  • IgG antibodies target platelet glycoprotein
    complexes IIb-IIIa and Ib-IX.
  • Sensitized platelets are removed by the spleen.
  • Increased bleeding time normal PT PTT.

14
Petechiae and Purpura due to ITP
15
Acute Immune Thrombocytopenic Purpura
  • Similar to ITP but occurs only in childhood.
  • Abrupt thrombocytopenia due to viral cause.
  • Resolves spontaneously within 6 months.

16
Drug-induced thrombocytopenia
  • Drugs involved are heparin, quinine, quinidine,
    sulfonamide antibiotics.
  • Type I HIT less severe, occurs rapidly after
    therapy.
  • Type II HIT more severe, occurs 5-16 days after
    therapy.
  • HIT is caused by an immune reaction against a
    complex of heparin and platelet factor 4, which
    produces immune complexes.

17
Heparin-induced thrombocytopenia
18
Heparin-induced thrombocytopenia
19
Heparin-induced thrombocytopenia
  • HIT is not usually severe, with low counts rarely
    lt20,000/µL.
  • Not associated with bleeding
  • Increases the risk of thrombosis.
  • Caused by low-molecular weight heparin (LMWH)
  • More commonly caused by unfractionated heparin
    (UFH).
  • HIT (antiheparin/PF4) antibodies can be detected
    using enzyme-linked immunoassay (ELISA) with
    PF4/polyanion complex as the antigen.
  • A platelet activation assay confirmatory test can
    also be used.
  • Heparin given with warfarin has decreased chance
    of causing HIT compared to giving heparin alone.

20
Autoimmune thrombocytopenia vs HIT
21
Question
  • What test would you order in order to confirm HIT?

22
Answer (two tests)
  • Test for PF4 antibodies (PF4 ELISA).
  • Serotonin release assay.

23
Chloramphenicol-induced thrombocytopenia
  • Chloramphenicol affects the bone-marrow causing
    anemia, leukopenia, thrombocytopenia.
  • Chloramphenicol causes an idiosyncratic response
    manifested by aplastic anemia in patients
    receiving prolonged therapy.

24
HIV-associated thrombocytopenia
  • Decreased platelet production and increased
    platelet destruction. Three causes
  • Existence of CD4 receptor on megakaryocytes makes
    them prone to destruction.
  • HIV causes hyperplasia and dysregulation of B
    cells, producing IgG antibodies which target
    platelet glycoprotein complexes IIb-IIIa and
    Ib-IX resulting in thrombocytopenia.
  • Autoantibodies may cross-react with
    HIV-associated gp120 acting as opsonins, thus
    promoting phagocytosis of platelets in the spleen.

25
TTP HUS
  • TTP is caused by bone marrow transplantation,
    cancer, chemotherapy and manifested as
    microangiopathic hemolytic anemia,
    thrombocytopenia, renal failure, neurologic
    findings, and fever.
  • HUS caused by infection and is manifested as
    acute renal failure, microangiopathic hemolytic
    anemia, and thrombocytopenia.
  • Deficiency of ADAMTS 13 produces a defective
    protease causing very high molecular weight
    multimers of vWF to accumulate in plasma
    promoting platelet microaggregate formation
    leading to thrombocytopenia.

26
Thrombotic ThrombocytopenicPurpura
27
Disseminated Intravascular Coagulation
  • DIC is an acute, subacute, or chronic
    thrombohemorrhagic disorder occurring secondary
    to a variety of conditions.
  • Begins with extrinsic (release of tissue factor)
    and intrinsic (factor XII activation) clotting
    cascade activation.
  • Both pathways cause platelet consumption and
    thrombi formation leading to thrombocytopenia.

28
Arterial thrombosis secondary to sepsis-induced
DIC
29
Endothelial injury induced thrombocytopenia
  • Endothelial injury can activate tissue factor,
    which activates TNF, which up-regulates leukocyte
    adhesion, which damages endothelial cells and
    releasing free radicals and proteases causing
    activation of both the extrinsic and intrinsic
    pathways leading to thrombocytopenia.

30
Pancytopenia
  • Caused by bone marrow failure, radiation,
    auto-immune diseases, drugs, infections.
  • Pancytopenia is a combination of anemia,
    leukopenia, and thrombocytopenia.

31
Thrombocytopenia Management
  • Rule out pseudothrombocytopenia (in vitro
    artifactual IgG or IgM-induced clumping of
    platelets).
  • HP (splenomegaly, liver disease).
  • CBC.
  • Peripheral blood smear.
  • Medication list.
  • Bone marrow biopsy.

32
Drug-induced thrombocytopenia
33
Normal Peripheral Blood
34
Pseudothrombocytopenia
35
MacrothrombocytopeniaLarge platelets
36
Schistocytes in microangiopathic hemolytic anemia
(HUS/TTP).
37
Complications of thrombocytopenia
  • Intracranial hemorrhage.
  • GI bleeding.
  • Epistaxis.
  • Menorrhagia.
  • Gingivorrhagia.

38
When do you treat?
  • You treat thrombocytopenia when the platelet
    count is less than 50,000/µL.
  • You do not treat when the platelet count is over
    50,000/µL.
  • You do a bone-marrow biopsy in patients
    presenting with isolated thrombocytopenia who are
    older than 60 years in order to rule out
    myelodysplasia.

39
Related medications - Prednisone
  • Methylprednisolone sodium succinate (SOLU-MEDROL)
  • Used to decrease bleeding tendency.
  • Patients with refractory ITP may respond.
  • Dosed as 1-1.5kg/mg.

40
Related medications - Argatroban
  • Anticoagulant or platelet aggregation inhibitor.
  • Prevents the activation of coagulation factors V,
    VIII, and XIII protein C.
  • Used to replace heparin in patients with
    heparin-induced thrombocytopenia.

41
Related medications - Lepirudin
  • The same as hirudin except that it contains
    leucine instead of isoleucine at the N-terminal
    end of the molecule and an absent sulfate group
    on the tyrosine at position 63.
  • It binds thrombin and prevents thrombus or clot
    formation.
  • Alternative to heparin in HIT.
  • Can also cause thrombocytopenia.

42
Related medications - Bivalirudin
  • Used for treatment of HIT in patients who have
    undergone percutaneous coronary intervention
    (PCI).
  • Inhibits thrombin
  • Very short half-life.

43
Related medications - Oprelvekin
  • Recombinant IL-11
  • Produced by E. coli.
  • Increases platelet levels which were reduced due
    to chemotherapy.
  • IL-11 is a growth factor that stimulates
    proliferation of hematopoietic stem cells and
    megakaryocyte progenitor cells resulting in
    increased platelet production.

44
Related medications - Eltrombopag
  • Used to treat ITP.
  • MOA is unknown.
  • Oral thrombopoeitin (TPO) receptor agonist.
  • May reduce antibodies to platelets.

45
Related medications - IgG
  • Used to treat ITP.
  • Removes offending immune complexes composed of
    viral particles.
  • Low-dose anti-D antibodies (Rhogam) can also be
    used to treat ITP.

46
Other thrombocytopenia treatments
  • Splenectomy in severe cases and if there is
    recurrent bleeding after steroids.
  • Plasmapheresis (TTP).
  • Dialysis (RF).
  • Platelet transfusion (active bleeding or severe
    cases).
  • Lithium carbonate or folate.

47
Thrombocytopenia case study
  • A 21-year-old man with no significant PMH
    presents with complaints of hematuria and mucosal
    bleeding while brushing his teeth. The patient
    complains of intermittent "ringing in the ears."
    He denies any drug or alcohol use. He has no
    family history of bleeding disorders. Petechiae
    are noted in the oral cavity, as is dried blood
    in the nostrils.
  • Hematocrit 32 WBC 8,000/mm3 with 60
    neutrophils.
  • Platelet count 13,000 PT 13 seconds PTT 28
    seconds LDH 1,200 U/L.
  • Elevated indirect bilirubin.
  • Coombs' test is positive abdominal examination
    is normal.
  • Peripheral smear shows spherocytes.
  • A) Alport's syndromeB) Bernard-Soulier
    syndromeC) Felty's syndromeD) Thrombotic
    thrombocytopenic purpuraE) Evans' syndromeF)
    Idiopathic thrombocytopenic purpura (ITP)

48
Answer
  • Answer E
  • Evans' syndrome is the association of autoimmune
    destruction of RBC, WBCs, and platelets.
  • TX steroids and/or splenectomy.

49
References
  • Robbins Pathology
  • Harrisons IM
  • First Aid for USMLE
  • The Pharmacological Basis of Therapeutics
  • Dorland's Medical Dictionary
  • www.usmleforum.com
Write a Comment
User Comments (0)
About PowerShow.com